BCI
MRVI icon

Brinker Capital Investments’s Maravai LifeSciences MRVI Stock Holding History

Brinker Capital Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1K Buy
+11,327
New +$38.4K ﹤0.01% 1924
2025
Q3 		– Sell
-321,879
Closed -$776K – 2101
2025
Q2 		$776K Buy
321,879
+82,522
+34% +$173K 0.01% 1326
2025
Q1 		$529K Buy
239,357
+142,665
+148% +$564K 0.01% 1398
2024
Q4 		$527K Sell
96,692
-39,057
-29% -$251K 0.01% 1332
2024
Q3 		$1.13M Buy
135,749
+6,177
+5% +$53.4K 0.01% 990
2024
Q2 		$928K Buy
129,572
+14,333
+12% +$124K 0.01% 1026
2024
Q1 		$999K Buy
115,239
+14,519
+14% +$98.2K 0.01% 983
2023
Q4 		$692K Buy
100,720
+35,564
+55% +$230K 0.01% 1091
2023
Q3 		$652K Buy
65,156
+11,564
+22% +$127K 0.01% 1100
2023
Q2 		$666K Buy
53,592
+22,833
+74% +$308K 0.01% 1104
2023
Q1 		$431K Buy
30,759
+15,690
+104% +$225K 0.01% 1191
2022
Q4 		$216K Buy
+15,069
New +$237K ﹤0.01% 1273
2022
Q3 		– Sell
-15,520
Closed -$441K – 1373
2022
Q2 		$441K Buy
+15,520
New +$492K 0.01% 1023

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brinker Capital Investments's MRVI Position: Q1 2026 in Review

Brinker Capital Investments opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 11,327 shares worth $32.1K. The stake represents ﹤0.01% of the portfolio and ranks #1924 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in MRVI as recently as Q2 2025.

Brinker Capital Investments first reported a position in MRVI in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.13M in Q3 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Brinker Capital Investments held 11,327 shares of Maravai LifeSciences worth $32.1K as of Q1 2026.
  • Maravai LifeSciences was a new Brinker Capital Investments position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1924 holding.
  • Brinker Capital Investments first reported a position in Maravai LifeSciences in Q2 2022 and has held it in 13 quarters since.
  • Brinker Capital Investments's Maravai LifeSciences position peaked at $1.13M in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.